AUTOREGULATION SYSTEM AND METHOD USING TISSUE OXIMETRY AND BLOOD PRESSURE

DE602022026123T2Active Publication Date: 2025-12-03BECTON DICKINSON & CO
0 Cites 0 Cited by

Patent Information

Application Number
DE602022026123
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-08-10
Filing Date
2022-05-02
Publication Date
2025-12-03
Estimated Expiration
2042-05-02

AI Technical Summary

Technical Problem

Existing methods for monitoring autoregulation in mammals are inaccurate due to confounding factors that affect tissue oxygenation parameters independently of autoregulation function, such as blood carbon dioxide levels and extracerebral blood flow, leading to unreliable determination of autoregulation states.

Method used

A method and apparatus using a tissue oximeter and blood pressure sensing device to continuously monitor tissue oxygenation parameters and blood pressure, identifying and accounting for confounding factors to determine an accurate autoregulation function state by analyzing tissue oxygenation parameter and blood pressure trends.

Benefits of technology

Enables precise determination of autoregulation function states by filtering out confounding factors, allowing for the identification of lower and upper limits of autoregulation, thereby improving the accuracy of autoregulation monitoring.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.